An in vivo combined induction strategy of whole cancer cell vaccines triggers systemic immunity to eradicate triple-negative breast cancer
- 16 July 2025
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 385, 114045
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81973271)
This publication has 62 references indexed in Scilit:
- Lymphatic-localized Treg-mregDC crosstalk limits antigen trafficking and restrains anti-tumor immunityCancer Cell, 2024
- Role of myeloid-derived suppressor cells in tumor recurrenceCancer and Metastasis Reviews, 2023
- Tumor-associated neutrophils and neutrophil-targeted cancer therapiesBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2022
- Sequential administration of sialic acid-modified liposomes as carriers for epirubicin and zoledronate elicit stronger antitumor effects with reduced toxicityInternational Journal of Pharmaceutics, 2021
- A Sialylated-Bortezomib Prodrug Strategy Based on a Highly Expressed Selectin Target for the Treatment of Leukemia or Solid TumorsPharmaceutical Research, 2019
- Targeted delivery of ibrutinib to tumor-associated macrophages by sialic acid-stearic acid conjugate modified nanocomplexes for cancer immunotherapyActa Biomaterialia, 2019
- Targeted delivery of pixantrone to neutrophils by poly(sialic acid)-p-octadecylamine conjugate modified liposomes with improved antitumor activityInternational Journal of Pharmaceutics, 2018
- Melittin, a major peptide component of bee venom, and its conjugates in cancer therapyCancer Letters, 2017
- Targeting dendritic cells in lymph node with an antigen peptide-based nanovaccine for cancer immunotherapyBiomaterials, 2016
- A review of current developments in process and quality control for injection moldingAdvances in Polymer Technology, 2005